NewBridge Pharmaceuticals

Focus: NewBridge Pharmaceuticals is an in-licensing and marketing-focused pharmaceutical company headquartered in Dubai, specializing in neurological therapeutics for African and Middle Eastern markets.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About NewBridge Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow NewBridge Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Practical Body Image

Body Image

N/A

Clinical Trials (1)

NCT04064255Evaluation of Practical Body Image Therapy for Anorexia Nervosa V1

N/A

Help build intelligence for NewBridge Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to build pharma presence in high-growth emerging markets (Africa, Middle East) with less saturated competition than developed regions
In-licensing model offers exposure to deal-making, market access strategy, and regulatory navigation across diverse healthcare systems
Potential for rapid career advancement in smaller organization with regional expansion trajectory

Watch Out For

No active job openings currently listed and minimal public hiring signals suggest limited growth or potential contraction
Absence of clinical pipeline (zero Phase 1-3 trials) indicates limited R&D infrastructure and future innovation upside
Sparse financial and operational transparency raises questions about company viability, funding sustainability, and career stability

Generated by Claude from NewBridge Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Self-esteem group

Self Esteem

N/A

Clinical Trials (1)

NCT04072510Evaluation of Self-esteem Group Therapy for Eating Disorders

N/A

Newbridge Eating disorders Activity Treatment group

Eating Disorders in Adolescence

N/A

Clinical Trials (1)

NCT04552639Evaluation of Compulsive Exercise Group Therapy for Eating Disorders

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2010

Portfolio: 3 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo